Palo Alto’s 180 Life Sciences is making a radical pivot, ditching biotech for crypto. With a $425 million private placement backed by Ethereum’s elite, the soon-to-be...
Palo Alto’s 180 Life Sciences is making a radical pivot, ditching biotech for crypto. With a $425 million private placement backed by Ethereum’s elite, the soon-to-be...